Product
TCRα/β+
1 clinical trial
8 indications
Indication
Acute Lymphoblastic LeukemiaIndication
Acute Myeloid LeukemiaIndication
Myelodysplastic SyndromesIndication
NK Cell LeukemiaIndication
Hodgkin lymphomaIndication
Non-Hodgkin LymphomaIndication
Juvenile Myelomonocytic LeukemiaIndication
Chronic Myeloid LeukemiaClinical trial
TCRαβ-depleted Progenitor Cell Graft With Additional Memory T-cell DLI, Plus Selected Use of Blinatumomab, in Naive T-cell Depleted Haploidentical Donor Hematopoietc Cell Transplantation for Hematologic MalignanciesStatus: Active (not recruiting), Estimated PCD: 2024-07-01